Clinical Trials Browser

Phase 4 × Unknown × lenvatinib × Clear all

NCT05949424 2023-11-29

OPTI-DOSE

Phase 4 Unknown

BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT04127396 2021-07-23

Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular